TelyRx Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	79.46	42.92	9.53	0.03
Revenue Growth	138.64%	350.27%	35207.41%	-
Cost of Revenue	34.11	19.61	6.02	0.03
Gross Profit	45.35	23.32	3.51	0
Selling, General & Admin	58.04	27.3	7.16	0.72
Operating Expenses	59.24	28.08	7.44	0.75
Operating Income	-13.89	-4.76	-3.93	-0.75
Interest Expense	-0.61	-0.66	-0.93	-0.89
Other Non Operating Income (Expenses)	-0.55	0.02	-	-
EBT Excluding Unusual Items	-15.04	-5.41	-4.86	-1.64
Other Unusual Items	-	-	0.03	-
Pretax Income	-15.04	-5.41	-4.83	-1.64
Income Tax Expense	0.04	0.02	-	-
Earnings From Continuing Operations	-15.07	-5.43	-4.83	-1.64
Earnings From Discontinued Operations	-	-	-8.65	-2.76
Net Income	-15.07	-5.43	-13.48	-4.39
Net Income to Common	-15.07	-5.43	-13.48	-4.39
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	30	11	8	-
Shares Outstanding (Diluted)	30	11	8	-
Shares Change	187.93%	40.47%	-	-
EPS (Basic)	-0.50	-0.51	-1.77	-
EPS (Diluted)	-0.50	-0.51	-1.77	-
EPS Growth	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	-8.92	-1.36	-3.07	-2.51
Free Cash Flow Per Share	-0.30	-0.13	-0.40	-
Gross Margin	57.08%	54.32%	36.84%	7.41%
Operating Margin	-17.47%	-11.10%	-41.19%	-2762.96%
Profit Margin	-18.97%	-12.64%	-141.44%	-16274.07%
Free Cash Flow Margin	-11.22%	-3.16%	-32.17%	-9277.78%
EBITDA	-13.38	-4.67	-3.92	-0.71
EBITDA Margin	-16.84%	-10.87%	-41.10%	-
D&A For EBITDA	0.51	0.1	0.01	0.03
EBIT	-13.89	-4.76	-3.93	-0.75
EBIT Margin	-17.47%	-11.10%	-41.19%	-